We will be doing maintenance on our sites on 10/1/2014 from 7am - 8am CST to improve your online experience. We apologize for the inconvenience.

Advertising Policy

For information about rates or to place an advertisement in Annals, contact Danny Wang, Elsevier, 212-633-3158. For clarification or additional information related to advertising policies for Annals of Emergency Medicine, contact the Annals Director at ACEP, 800-803-1403 or 972-550-0911, fax 972-580-0051.

It is the responsibility of any advertiser in Annals of Emergency Medicine to comply with the laws and regulations applicable to marketing and sale of products. Acceptance of advertising in Annals should not be construed as a guarantee that the manufacturer has complied with such laws and regulations or that Annals, the American College of Emergency Physicians, or the Publisher endorses such a product or service. Annals does not review products and services prior to accepting an advertisement; acceptance of an ad in no way verifies that claims made are accurate and is not an endorsement of the product or service.

The number of pages of advertising in Annals shall not exceed the number of editorial pages in any issue.

General Eligibility Requirements

Products or services eligible for advertising in Annals of Emergency Medicine must be germane to (a) the practice of medicine, (b) medical education, or (c) health care delivery and shall be commercially available. The Annals staff may ask for consultation from the Editor in Chief to determine whether products intended for preventive, diagnostic, or therapeutic purposes are eligible for advertising in Annals. Special requirements for various types of advertising follow.

  • Drugs: A drug advertisement is the advertiser's message and should not be considered a physician's sole source of information regarding a product. The regulations of the Food and Drug Administration provide exacting legal controls over the claims that drug advertisers may make for their products and require them to state contraindications, hazards, etc. Any products approved by the FDA for advertising in the United States are eligible for advertising in Annals.

    Adherence to legal requirements concerning the content of drug advertising is the manufacturer's responsibility. A pharmaceutical product requiring approval of a New Drug Application by the FDA will not be eligible for advertising until such approval has been granted. However, as is common practice in the advertising industry, Annals will allow pharmaceutical manufacturers to run "corporate" or "teaser" ads prior to a product's official FDA approval. Such advertisements may not mention specific product names.

  • Medical apparatus, instruments, or devices: As with drug advertising, it is the manufacturer's responsibility to adhere to FDA regulations governing the manufacture of medical devices. Complete scientific and technical data concerning the product's safety, operation, and usefulness should be made available on request. Annals may decline advertising for any product being investigated or challenged by a government agency regarding claims made in marketing the product.

  • Insurance programs: Statements about insurance policy benefits, losses covered, or premiums must be complete and truthful. Claims made shall include full disclosure of expectations, reduction, and limitations affecting the basic provisions of the policy. Each advertisement for insurance should include a statement indicating the number of states in which the company is licensed.

  • Classified advertising: The primary purpose of Annals' classified advertising is to provide information related to physician placement opportunities ("help wanted" ads). Annals also will accept for placement in the Classified section ads for residency positions, fellowship programs, computer software, and physician services such as billing and recruitment.

  • Alcoholic beverages, tobacco products, investment opportunities: These products are not eligible for advertising.

Guidelines for Advertising Copy and Graphics

If an ad does not conform to the following requirements, the advertiser or its agent will be contacted and will be given the opportunity to submit corrected advertising materials, or to authorize Annals to make the necessary changes at the advertiser's expense. However, Annals cannot guarantee that the corrected advertisement will be included in the issue intended.

  1. Layout, artwork, and format of ads shall be such as to avoid confusion with the editorial content of Annals of Emergency Medicine. Annals may add the word "advertisement" to an ad to prevent such confusion.

  2. All advertisements should clearly identify the advertiser and the product or service being offered. In the case of drug advertisements, the full generic name of each active ingredient shall appear. The only exceptions to this policy are the "confidential reply box" option made available to classified advertisers of physician placement opportunities, and the "corporate" type of advertisement mentioned above, which may not state the name of a specific product until it receives FDA approval, but does provide the name of the advertising company.

  3. The words "emergency room" and "ER" are not acceptable in any context. These terms must be changed to "emergency department" or "ED," whichever is more applicable.

  4. The terms "emergency medicine physician," "emergency room physician," and "emergency department physician" must be changed to "emergency physician."

  5. The term "board eligible" as it relates to emergency medicine board certification is a misnomer and will be changed to "board prepared." The term "board eligible" is acceptable when it refers to board certification in a specialty other than emergency medicine; however, if an ad specifies certification in some other specialty to the exclusion of emergency medicine, the ad must be changed to include emergency medicine certification or preparation.

  6. Ads for CME products and services that are specific to preparation for Board certification must include the phrase "Not affiliated with ABEM."

  7. Unfair comparison or unwarranted disparagements of a competitor's product or service will not be allowed.

  8. All price comparison advertising must meet the following guidelines: (a) the source of all prices quoted must be identified within the advertisement, and substantiation must be available upon request; (b) if a price comparison is based on the advertiser's own research, that research must be available upon request; (c) all advertising about prices must contain a qualification similar to the following: "Prices will vary from pharmacy to pharmacy due to location and services offered"; (d) for pharmaceutical products, in the absence of standard retail price comparison data, the manufacturer's suggested price may be used; (e) for over-the-counter products, price comparisons must be based on manufacturer's suggested retail or resale price.

  9. Advertisements should not be deceptive or misleading. Exaggerated or extravagantly worded copy will not be allowed.

  10. Annals may refuse any advertisement for any reason. Advertisements will not be accepted if they appear to be indecent or offensive in either text or artwork, or contain content of a personal, racial, or religious character. The decision as to acceptance will be made by the Annals Director, who may seek consultation from the Editor in Chief.

Advertising Review Process

In all cases, Annals has the right to make the final decision regarding the eligibility of an ad.

  1. All advertisements must be submitted 10 days before the closing date, for review by the Annals editorial staff to ensure compliance with Annals advertising policies. Any previously approved ad that has been changed must be resubmitted for review in its most current form 10 days prior to the closing date.

  2. For preprinted advertising inserts, the advertiser or its agent must receive paper stock approval from the Publisher prior to the issue's closing date, in addition to copy approval by the Annals Director.

  3. Questions about the eligibility of any advertisement raised by an Annals subscriber, an Editorial Board member, or any other party will be referred to the Annals Director, who may seek the opinions of consultants and the Editor in Chief to determine the suitability of the claims and the ad itself. The Annals Editor in Chief will be kept informed on a regular basis about the evaluation of advertising, especially ads that are refused due to non-compliance with these guidelines.

Advertising Placement and Rates

  1. Annals makes every effort to separate ads for competing products.

  2. Commercial advertisements in Annals are "welled" throughout the journal, which means that ads are grouped between significant editorial sections.

  3. Premium positions are available at extra cost to the advertiser.

  4. Advertisements for educational products, services, and conferences are usually placed in the Calendar section.

  5. Classified ads are published in the Classified section of the journal. Both line and display advertisements are available in this section.

  6. Advertisements will not be placed adjacent to any editorial matter that discusses the product being advertised, nor adjacent to any article reporting research on the advertised product.

  7. Inquiries about advertising placement and current rates should be directed to the Publisher.

Advertising Policy Development and Revision

These advertising policies were developed by the members of the Annals Editorial Board, staff, and the Publisher, and approved by the ACEP Board of Directors. Annals may change any of these polices in light of developments in medicine, trends in the advertising industry, and the changing needs of the journal.

For clarification or additional information related to advertising policies for Annals of Emergency Medicine, contact the Annals Director.

This advertising policy was approved by the ACEP Board of Directors on June 19, 1998.

Related Links

 ScribeAmerica
 
Feedback
Click here to
send us feedback